Cargando…
Histopathology and genetic susceptibility in COVID‐19 pneumonia
BACKGROUND: The clinical features of COVID‐19 pneumonia range from a mild illness to patients with a very severe illness with acute hypoxemic respiratory failure requiring ventilation and Intensive Care Unit admission. AIMS: To provide a brief overview of the existing evidence for such differences i...
Autores principales: | von der Thüsen, Jan, van der Eerden, Menno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267318/ https://www.ncbi.nlm.nih.gov/pubmed/32353898 http://dx.doi.org/10.1111/eci.13259 |
Ejemplares similares
-
Increase of mast cells in COVID‐19 pneumonia may contribute to pulmonary fibrosis and thrombosis
por: Wismans, Leonoor V, et al.
Publicado: (2022) -
Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: the VAPORISE randomized-controlled trial
por: Stokker, Jason, et al.
Publicado: (2020) -
Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia
por: von der Thüsen, Jan H., et al.
Publicado: (2020) -
Pleuroparenchymal Fibroelastosis: Its Pathological Characteristics
por: von der Thüsen, Jan H.
Publicado: (2013) -
Use of Antibiotics for Exacerbations of COPD
por: Daniels, Johannes M.A., et al.
Publicado: (2017)